Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

EXOSC1 Inhibitors

EXOSC1 inhibitors encompass a range of chemical compounds designed to specifically target and hinder the activity of the EXOSC1 protein, a component of the exosome complex involved in RNA processing and degradation. EXOSC1, as part of the RNA exosome, plays a crucial role in the maturation and degradation of various RNA molecules within the cell. Inhibitors of EXOSC1 function to disrupt this process by binding directly to the protein or interfering with its associated pathways, leading to the accumulation of RNA substrates that would otherwise be degraded. The action of these inhibitors can affect the RNA exosome's role in the regulation of gene expression, RNA processing, and cellular response to stress, which are vital for maintaining normal cellular function.

The design of EXOSC1 inhibitors is based on the understanding of the protein's structure and its interaction with RNA substrates. These inhibitors can act by mimicking the natural substrates of the exosome complex, thereby blocking the active site of the EXOSC1 protein and preventing it from binding to its RNA targets. Alternatively, they may interact with regulatory regions of EXOSC1, altering its conformation and thus its function within the exosome. By impeding the normal function of EXOSC1, these inhibitors can lead to a specific decrease in the degradation of certain classes of RNA, resulting in an upregulation of RNA species that are typically kept at low levels. The precise mechanisms by which EXOSC1 inhibitors exert their effects are diverse and can depend on the particular chemical structure of the inhibitor and its interaction with the EXOSC1 protein or its co-factors within the exosome complex.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Triptolide

38748-32-2sc-200122
sc-200122A
1 mg
5 mg
$90.00
$204.00
13
(1)

Triptolide targets multiple pathways, including the transcription of RNA. By inhi

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Actinomycin D intercalates DNA and prevents RNA synthesis. With reduced transcription, EXOSC1 has less RNA substrate for degradation, thus indirectly inhibiting its function.

Cordycepin

73-03-0sc-203902
10 mg
$101.00
5
(1)

Cordycepin is an adenosine analog that terminates RNA transcription. By halting the production of RNA, it indirectly limits the functional role of EXOSC1 in RNA decay.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$269.00
$1050.00
26
(2)

α-Amanitin inhibits RNA polymerase II which is necessary for mRNA synthesis. Reduced mRNA synthesis would lead to reduced EXOSC1-mediated RNA degradation.

DRB

53-85-0sc-200581
sc-200581A
sc-200581B
sc-200581C
10 mg
50 mg
100 mg
250 mg
$43.00
$189.00
$316.00
$663.00
6
(1)

DRB is an adenosine analog that inhibits RNA polymerase II, thus reducing RNA synthesis and indirectly impacting EXOSC1's RNA decay pathway.

β-Lapachone

4707-32-8sc-200875
sc-200875A
5 mg
25 mg
$112.00
$459.00
8
(1)

β-Lapachone has been shown to inhibit RNA polymerase I, leading to a decrease in rRNA synthesis. This would result in a reduced substrate for EXOSC1, thereby inhibiting its function.

Leptomycin B

87081-35-4sc-358688
sc-358688A
sc-358688B
50 µg
500 µg
2.5 mg
$107.00
$416.00
$1248.00
35
(2)

Leptomycin B inhibits the export of mRNA from the nucleus to the cytoplasm. By preventing mRNA export, EXOSC1's role in mRNA degradation in the cytoplasm is indirectly inhibited.

Flavopiridol

146426-40-6sc-202157
sc-202157A
5 mg
25 mg
$78.00
$259.00
41
(3)

Flavopiridol inhibits Cyclin-dependent kinases which are required for RNA polymerase II phosphorylation and subsequent RNA synthesis. This reduces EXOSC1's RNA degradation substrate.

Quercetin

117-39-5sc-206089
sc-206089A
sc-206089E
sc-206089C
sc-206089D
sc-206089B
100 mg
500 mg
100 g
250 g
1 kg
25 g
$11.00
$17.00
$110.00
$250.00
$936.00
$50.00
33
(2)

Quercetin can inhibit the phosphorylation of splicing factors, which may reduce mRNA processing and in turn, decrease the availability of RNA for EXOSC1-mediated decay.

Rocaglamide

84573-16-0sc-203241
sc-203241A
sc-203241B
sc-203241C
sc-203241D
100 µg
1 mg
5 mg
10 mg
25 mg
$275.00
$474.00
$1639.00
$2497.00
$5344.00
4
(1)

Rocaglamide inhibits translation initiation. By reducing the overall level of mRNA translation, there is less RNA for EXOSC1 to degrade, thus indirectly inhibiting its function.